Colchicine, a long established anti-inflammatory agent now used in several rheumatologic conditions, acts by inhibiting microtubular polymerization, as it binds equimolarly to tubulin molecules. Cytoskeletal microtubules are crucial in processes of cell viability, such as mitosis and intracellular vesicle motility.Gastrointestinal side effects are quite common and often minor in nature or duration, whereas neuromuscular toxicity is rare. We report 2 cases of colchicine myopathy in the context of very different clinical settings.
Cantarini, L., Volpi, N., Galeazzi, M., Giani, T., Fanti, F., Lucherini, O.M., et al. (2010). Colchicine myopathy and neuromyopathy: two cases with different characteristics. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 16(5), 229-232 [10.1097/RHU.0b013e3181e96342].
Colchicine myopathy and neuromyopathy: two cases with different characteristics
CANTARINI L.;VOLPI N.;GALEAZZI M.;GIANI T.;LUCHERINI O. M.;AGLIANÒ M.;GIANNINI F.;BALDARI C. T.;
2010-01-01
Abstract
Colchicine, a long established anti-inflammatory agent now used in several rheumatologic conditions, acts by inhibiting microtubular polymerization, as it binds equimolarly to tubulin molecules. Cytoskeletal microtubules are crucial in processes of cell viability, such as mitosis and intracellular vesicle motility.Gastrointestinal side effects are quite common and often minor in nature or duration, whereas neuromuscular toxicity is rare. We report 2 cases of colchicine myopathy in the context of very different clinical settings.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/20315
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo